Real‐life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1‐year follow‐up data report

Background Progressive supranuclear palsy (PSP) is a progressive neurodegenerative condition presenting with different clinical endophenotypes. The parkinsonian variant of PSP (PSP‐P) is characterised by early but fading responsiveness to high‐dose levodopa therapy; however, high‐dose oral therapy i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Brain and behavior Jg. 12; H. 9; S. e2547 - n/a
Hauptverfasser:	Metta, Vinod, Chaudhuri, K. Ray, Leta, Valentina, Mridula, Kandadai Rukmini, Koduri, Chaitanya, Deepak, Sai, Kalpala, Rakesh, Reddy, Nageswar, Chung‐Faye, Guy, Borgohain, Rupam
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States John Wiley & Sons, Inc 01.09.2022 John Wiley and Sons Inc Wiley
Schlagworte:	Antiparkinson Agents - therapeutic use Cosmetics Dementia Diabetes Dopamine Drug dosages Family medical history Follow-Up Studies Gait Hallucinations Hospitals Humans Hypertension intrajejunal levodopa‐carbidopa infusion Levodopa - adverse effects motor and nonmotor symptoms Original Parkinson Disease Parkinson's disease Parkinsonian variant of progressive supranuclear palsy Patients Quality of Life Sleep Supranuclear Palsy, Progressive India intrajejunal levodopa-carbidopa infusion Parkinsonian variant of progressive supranuclear palsy motor and nonmotor symptoms quality of life
ISSN:	2162-3279, 2162-3279
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!